Pre-Filled Syringes West Coast 2019
3rd - 4th June, 2019 (San Diego, USA)
Pre-Filled Syringes West Coast will gather a global audience of medical device experts and PFS industry leaders to discuss new developments and showcase the latest and advancements, keeping you at the forefront of a booming industry.
The competitive PFS market has sparked great improvements as devices strive for higher quality, safety, and patient satisfaction. Pre-Filled Syringes West Coast is the perfect platform to strengthen knowledge in key principles such as human factors and patient centricity, connectivity and digital health, container closure integrity, the therapeutic opportunities of pre-filled, and manufacturing in the landscape of complex biologics, whilst honing in on emerging trends for parenteral devices.
Benefits of attending:
Join us in San Diego to:
- Obtain insights into the new FDA draft guidance on human factors submissions, and the European Medical Device Regulation (EU MDR)
- Discover key innovations in digital health and how it can benefit pre-filled syringes
- Understand how silicon is being used to enhance formulation
- Explore the latest case studies in therapeutic opportunities
- Highlight the emerging trends of connected health and the future of drug delivery device designs
- Cutting edge industry insight on manufacturing processes and techniques
Who should attend:
Executives, Directors, VPs, Heads, Principals, Managers of:
- Pre-Filled Syringes/ PFS
- Device/ Device Engineering
- Human Factor
- Container Closure Integrity
- Sterile Manufacturing
- Regulatory Affairs
or anyone who works with Pre-Filled Syringes/ Autoinjectors within pharmaceutical, biotech and solution providers.
Abbott Laboratories; AbbVie; Advanced Molding Technologies; Aegerion Pharmaceuticals; Ajinomoto Althea, Inc.; Allergan; Allergen Inc; Almac Group; Amgen; Antares Pharma; Aptar Pharma; Baxter Healthcare; BCM Group LLC; BioMarin; Boehringer Ingelheim; Connecticut Spring & Stamping; Credence MedSystems; Execution Metrics, Inc; Ferring Pharmaceuticals; Fresenius-Kabi; Genentech; Genentech, Inc.; Gilead Sciences; Glenmark Pharmaceuticals; Harro Höfliger; Inovio Pharmaceuticals; iO Lifesciences; Ionis Pharmaceuticals, Inc.; Matchstick; MedImmune; MedImmune Inc; MedImmune LLC; Medizap; Medtronic; Merck & Co.; Mitsubishi Gas Chemical America Inc; MITSUBISHI GAS CHEMICAL COMPANY, INC; Nemera; Nipro PharmaPackaging; NOVO Engineering, Inc.; Novo Nordisk; Novo Nordisk A/S; One World DMG; Owen Mumford; Pfenex; Pfenex Inc; Pfizer CentreOne; RAUMEDIC INC; Regeneron; Regeneron Pharmaceuticals; Regeneron Pharmaceuticals, Inc.; Shire; Smithers Rapra; Steri-Tek; Stevanato Group S.p.A; Subcuject ApS; Suttons Creek Inc; Terumo Corporation; Terumo Medical Corporation; Terumo Pharmaceutical Solutions; UserWise, Inc.; W. L. Gore & Associates, Inc.; West Pharmaceutical Services,; West Pharmaceutical Services, Inc.; West Pharmaceuticals Services Inc; Worrell; Xeris Pharmaceuticals; ZebraSCI; zebrasci inc; ZEON; ZEON CORPORATION; Zeon Specialty Materials Inc;